BCPC - Balchem Corporation
NASDAQ
->
Basic Materials
->
Specialty Chemicals
New Hampton,
United States
Type: Equity
BCPC price evolution
BCPC
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $60.35 | $64.45 | $76.95 | $66.86 |
| Short term investments | ||||
| Net receivables | $139.88 | $125.28 | $129.01 | $125.11 |
| Inventory | $110.38 | $109.52 | $116.35 | $124.95 |
| Total current assets | $324.86 | $314.24 | $341.22 | $336.53 |
| Long term investments | ||||
| Property, plant & equipment | $293.04 | $295.9 | $287.06 | $289.81 |
| Goodwill & intangible assets | $953.58 | $970.12 | $958.71 | $976.9 |
| Total noncurrent assets | $1263.84 | $1282.97 | $1262.26 | $1282.7 |
| Total investments | ||||
| Total assets | $1588.7 | $1597.21 | $1603.48 | $1619.23 |
| Current liabilities | ||||
| Accounts payable | $59.8 | $55.5 | $49.7 | $56.32 |
| Deferred revenue | ||||
| Short long term debt | $4.05 | $4.22 | $3.86 | $4.09 |
| Total current liabilities | $124.42 | $148.49 | $108.04 | $114.39 |
| Long term debt | $317.44 | $326.11 | $395.81 | $420.75 |
| Total noncurrent liabilities | $385.48 | $394.74 | $470.18 | $497.94 |
| Total debt | $321.49 | $330.33 | $399.67 | $424.85 |
| Total liabilities | $509.91 | $543.23 | $578.22 | $612.33 |
| Shareholders' equity | ||||
| Retained earnings | $926.47 | $897.49 | $896.38 | $867.31 |
| Other shareholder equity | -$3.87 | $8.69 | -$14.23 | $0.19 |
| Total shareholder equity | $1078.79 | $1053.98 | $1025.27 | $1006.9 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $64.45 | $66.56 | $103.24 | $84.57 |
| Short term investments | $5.99 | |||
| Net receivables | $125.28 | $131.58 | $117.41 | $98.21 |
| Inventory | $109.52 | $119.67 | $91.06 | $70.62 |
| Total current assets | $314.24 | $335.8 | $322.23 | $266.89 |
| Long term investments | ||||
| Property, plant & equipment | $295.9 | $290.79 | $246.81 | $236.51 |
| Goodwill & intangible assets | $970.12 | $982.8 | $618.61 | $651.12 |
| Total noncurrent assets | $1282.97 | $1288.71 | $877.09 | $898.96 |
| Total investments | $5.99 | |||
| Total assets | $1597.21 | $1624.51 | $1199.33 | $1165.84 |
| Current liabilities | ||||
| Accounts payable | $55.5 | $57.32 | $56.24 | $23.74 |
| Deferred revenue | ||||
| Short long term debt | $4.22 | $4.02 | $2.36 | $2.34 |
| Total current liabilities | $148.49 | $140.04 | $143.8 | $94.43 |
| Long term debt | $326.11 | $442.78 | $115.68 | $169.65 |
| Total noncurrent liabilities | $394.74 | $546.19 | $178.51 | $243.18 |
| Total debt | $330.33 | $460.61 | $118.04 | $171.99 |
| Total liabilities | $543.23 | $686.23 | $322.31 | $337.61 |
| Shareholders' equity | ||||
| Retained earnings | $897.49 | $814.49 | $732.14 | $656.74 |
| Other shareholder equity | $8.69 | -$7.15 | -$4.99 | $4.17 |
| Total shareholder equity | $1053.98 | $938.28 | $877.01 | $828.23 |
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $239.66 | $228.7 | $229.95 | $231.25 |
| Cost of revenue | $158.15 | $153.71 | $153.4 | $153.9 |
| Gross Profit | $81.51 | $74.99 | $76.54 | $77.35 |
| Operating activities | ||||
| Research & development | $4.1 | $3.94 | $3.87 | $3.79 |
| Selling, general & administrative | $35.74 | $32.72 | $29.06 | $30.72 |
| Total operating expenses | $39.84 | $35.98 | $32.93 | $34.51 |
| Operating income | $41.68 | $39.02 | $43.61 | $42.84 |
| Income from continuing operations | ||||
| EBIT | $42.25 | $38.56 | $43.07 | $43.56 |
| Income tax expense | $7.86 | $6.62 | $7.4 | $8.29 |
| Interest expense | $5.4 | $5.29 | $6.59 | $5.16 |
| Net income | ||||
| Net income | $28.99 | $26.65 | $29.07 | $30.11 |
| Income (for common shares) | $28.99 | $26.65 | $29.07 | $30.11 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $922.44 | $942.36 | $799.02 | $703.64 |
| Cost of revenue | $620.38 | $661.91 | $555.85 | $479.75 |
| Gross Profit | $302.06 | $280.45 | $243.17 | $223.9 |
| Operating activities | ||||
| Research & development | $15.05 | $12.19 | $13.52 | $10.33 |
| Selling, general & administrative | $127.81 | $123.07 | $102.15 | $102.42 |
| Total operating expenses | $142.18 | $135.26 | $115.67 | $112.75 |
| Operating income | $159.87 | $145.19 | $127.5 | $111.15 |
| Income from continuing operations | ||||
| EBIT | $159.87 | $144.02 | $127.69 | $110.86 |
| Income tax expense | $28.72 | $28.38 | $29.13 | $21.79 |
| Interest expense | $22.61 | $10.27 | $2.46 | $4.44 |
| Net income | ||||
| Net income | $108.54 | $105.37 | $96.1 | $84.62 |
| Income (for common shares) | $108.54 | $105.37 | $96.1 | $84.62 |
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Net income | $28.99 | $26.65 | $29.07 | $30.11 |
| Operating activities | ||||
| Depreciation | $13.67 | $14.06 | $13.8 | $13.43 |
| Business acquisitions & disposals | -$0.04 | -$0.29 | -$0.91 | |
| Stock-based compensation | $4.75 | $3.79 | $3.75 | $3.75 |
| Total cash flows from operations | $33.39 | $67.41 | $46.53 | $34.99 |
| Investing activities | ||||
| Capital expenditures | -$6.7 | -$11.57 | -$8.37 | -$6.35 |
| Investments | $2.74 | |||
| Total cash flows from investing | -$6.74 | -$11.87 | -$9.28 | -$3.61 |
| Financing activities | ||||
| Dividends paid | -$25.55 | -$0 | -$0 | |
| Sale and purchase of stock | $3.59 | $0.91 | -$0.04 | $1.3 |
| Net borrowings | -$8.06 | -$71.06 | -$25.06 | -$26.05 |
| Total cash flows from financing | -$30.02 | -$70.15 | -$25.1 | -$24.76 |
| Effect of exchange rate | -$0.72 | $2.1 | -$2.06 | $0.04 |
| Change in cash and equivalents | -$4.1 | -$12.51 | $10.1 | $6.66 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $108.54 | $105.37 | $96.1 | $84.62 |
| Operating activities | ||||
| Depreciation | $54.94 | $51.85 | $48.88 | $51.28 |
| Business acquisitions & disposals | -$1.54 | -$365.78 | $0.32 | $0.09 |
| Stock-based compensation | $16.05 | $13.22 | $10.8 | $8.3 |
| Total cash flows from operations | $183.76 | $138.54 | $160.51 | $150.49 |
| Investing activities | ||||
| Capital expenditures | -$36.01 | -$50.08 | -$37.45 | -$33.83 |
| Investments | $2.74 | -$0.15 | -$0.85 | |
| Total cash flows from investing | -$34.81 | -$416.01 | -$35.3 | -$34.59 |
| Financing activities | ||||
| Dividends paid | -$22.87 | -$20.71 | -$18.72 | -$16.7 |
| Sale and purchase of stock | $0.77 | -$32.21 | -$28.3 | $0.69 |
| Net borrowings | -$131.22 | $300.83 | -$55.16 | -$85.15 |
| Total cash flows from financing | -$153.32 | $246.68 | -$102.18 | -$101.16 |
| Effect of exchange rate | $2.26 | -$5.88 | -$4.37 | $4.16 |
| Change in cash and equivalents | -$2.11 | -$36.68 | $18.67 | $18.9 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $929.56M |
|---|---|
| EBITDA | $222.40M |
| EBIT | $167.44M |
| Net Income | $114.82M |
| Revenue Q/Q | 3.06% |
| Revenue Y/Y | -1.74% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | 7.17% |
| ROE | 11.03% |
| Debt/Equity | 0.52 |
|---|---|
| Net debt/EBITDA | 2.02 |
| Current ratio | 2.61 |
| Quick ratio | 1.72 |